Skip to content

PRESSURE BIOSCIENCES, INC.: 10-Q filed 2021-11-17

What PRESSURE BIOSCIENCES, INC. reported in its quarterly report filed 2021-11-17 (fiscal Q3 2021): 36 published measures, 99 facts as tagged in accession 0001493152-21-029024.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-17
Fiscal period
fiscal Q3 2021
Accession
0001493152-21-029024 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PRESSURE BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-303,333,332USD
At 2020-12-312,302,779USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3023,312,592USD
At 2020-12-3119,220,371USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-30-19,979,260USD
At 2021-06-30-22,302,893USD
At 2021-03-31-20,527,363USD
At 2020-12-31-16,917,592USD
At 2020-09-30-14,536,380USD
At 2020-06-30-14,211,986USD
At 2020-03-31-13,659,933USD
At 2019-12-31-12,055,407USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-30663,651USD
At 2020-12-3118,540USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-4,951,113USD92
2021-01-01 to 2021-09-30-16,273,871USD273
2021-04-01 to 2021-06-30-4,745,171USD91
2021-01-01 to 2021-03-31-6,577,587USD90
2020-07-01 to 2020-09-30-3,278,748USD92
2020-01-01 to 2020-09-30-11,801,415USD274
2020-04-01 to 2020-06-30-4,568,782USD91
2020-01-01 to 2020-03-31-3,953,885USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-4,083,902USD273
2020-01-01 to 2020-09-30-3,906,764USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2021-01-01 to 2021-09-304,503USD273
2020-01-01 to 2020-09-301,663USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-30518,365USD92
2021-01-01 to 2021-09-301,687,166USD273
2020-07-01 to 2020-09-30533,862USD92
2020-01-01 to 2020-09-301,055,889USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-304,733,516USD273
2020-01-01 to 2020-09-304,774,804USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-4,503USD273
2020-01-01 to 2020-09-30-802,913USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-113,979,213USD
At 2020-12-31-96,465,807USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-302,366USD
At 2020-12-3116,490USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-07-01 to 2021-09-3095,248USD92
2021-01-01 to 2021-09-30219,943USD273
2020-07-01 to 2020-09-3066,542USD92
2020-01-01 to 2020-09-30373,652USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,242,558USD92
2021-01-01 to 2021-09-30-2,963,999USD273
2020-07-01 to 2020-09-30-818,762USD92
2020-01-01 to 2020-09-30-3,544,494USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-302,619,661USD
At 2020-12-311,057,471USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,330,101USD92
2021-01-01 to 2021-09-3011,524,306USD273
2020-07-01 to 2020-09-302,204,593USD92
2020-01-01 to 2020-09-305,501,272USD274

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-3022,674,927USD
At 2020-12-3118,517,711USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2021-09-30418,020USD
At 2020-12-31771,945USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-30538,632USD
At 2020-12-31131,228USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-30796,418USD
At 2020-12-31592,767USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-30282,622USD92
2021-01-01 to 2021-09-30839,072USD273
2020-07-01 to 2020-09-30247,432USD92
2020-01-01 to 2020-09-30807,724USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-308,345,120shares
At 2020-12-314,168,324shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3062,307,524USD
At 2020-12-3150,312,968USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30173,274USD
At 2020-12-31221,432USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30221,432USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2021-09-30527,038USD
At 2020-12-31527,039USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-09-30425,481USD
At 2020-12-31490,385USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-30620,960USD
At 2020-12-31314,936USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-6,199,176USD92
2021-01-01 to 2021-09-30-18,387,204USD273
2020-07-01 to 2020-09-30-3,675,718USD92
2020-01-01 to 2020-09-30-12,919,941USD274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,154,063USD92
2021-01-01 to 2021-09-302,788,779USD273
2020-07-01 to 2020-09-30684,807USD92
2020-01-01 to 2020-09-302,711,032USD274

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-07-01 to 2021-09-3060,627USD92
2021-01-01 to 2021-09-30119,280USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-3,708,555USD92
2021-01-01 to 2021-09-30-13,309,872USD273
2020-07-01 to 2020-09-30-2,459,986USD92
2020-01-01 to 2020-09-30-8,256,921USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-30802,084USD273
2020-01-01 to 2020-09-30530,009USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30407,404USD273
2020-01-01 to 2020-09-30101,057USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30203,651USD273
2020-01-01 to 2020-09-30-101,511USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-336,675USD273
2020-01-01 to 2020-09-30-109,445USD274

Inspect the source

Entity
PRESSURE BIOSCIENCES, INC. / CIK 0000830656
Captured
2026-09-21T17:17:15.791Z
SEC response SHA-256
9f53d6670ff4d2eff56cabbc6920a9205a8540e6e5042ac9d3ad7d038501b96e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000830656.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))